These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 24299076)

  • 1. Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
    Fenton-May AE; Dibben O; Emmerich T; Ding H; Pfafferott K; Aasa-Chapman MM; Pellegrino P; Williams I; Cohen MS; Gao F; Shaw GM; Hahn BH; Ochsenbauer C; Kappes JC; Borrow P
    Retrovirology; 2013 Dec; 10():146. PubMed ID: 24299076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms.
    Harper MS; Guo K; Gibbert K; Lee EJ; Dillon SM; Barrett BS; McCarter MD; Hasenkrug KJ; Dittmer U; Wilson CC; Santiago ML
    PLoS Pathog; 2015; 11(11):e1005254. PubMed ID: 26529416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha.
    Ashokkumar M; Sonawane A; Sperk M; Tripathy SP; Neogi U; Hanna LE
    Sci Rep; 2020 Feb; 10(1):2747. PubMed ID: 32066770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon α subtypes in HIV infection.
    Sutter K; Dickow J; Dittmer U
    Cytokine Growth Factor Rev; 2018 Apr; 40():13-18. PubMed ID: 29475588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.
    Guo K; Shen G; Kibbie J; Gonzalez T; Dillon SM; Smith HA; Cooper EH; Lavender K; Hasenkrug KJ; Sutter K; Dittmer U; Kroehl M; Kechris K; Wilson CC; Santiago ML
    PLoS Pathog; 2020 Oct; 16(10):e1008986. PubMed ID: 33064743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Plasmacytoid Dendritic Cell Response to Transmitted/Founder and Nontransmitted Variants of HIV-1.
    Schwartz JA; Zhang H; Ende Z; Deymier MJ; Lee T; Singer J; Mazzulli T; Hunter E; Ostrowski MA
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapting SHIVs In Vivo Selects for Envelope-Mediated Interferon-α Resistance.
    Boyd DF; Sharma A; Humes D; Cheng-Mayer C; Overbaugh J
    PLoS Pathog; 2016 Jul; 12(7):e1005727. PubMed ID: 27399306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness.
    Iyer SS; Bibollet-Ruche F; Sherrill-Mix S; Learn GH; Plenderleith L; Smith AG; Barbian HJ; Russell RM; Gondim MV; Bahari CY; Shaw CM; Li Y; Decker T; Haynes BF; Shaw GM; Sharp PM; Borrow P; Hahn BH
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E590-E599. PubMed ID: 28069935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance.
    Deymier MJ; Ende Z; Fenton-May AE; Dilernia DA; Kilembe W; Allen SA; Borrow P; Hunter E
    PLoS Pathog; 2015 Sep; 11(9):e1005154. PubMed ID: 26378795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Inhibition of HIV Replication by the 12 Interferon Alpha Subtypes.
    Tauzin A; Espinosa Ortiz A; Blake O; Soundaramourty C; Joly-Beauparlant C; Nicolas A; Droit A; Dutrieux J; Estaquier J; Mammano F
    J Virol; 2021 Jul; 95(15):e0231120. PubMed ID: 33980591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a different susceptibility of primate lentiviruses to type I interferons.
    Cordeil S; Nguyen XN; Berger G; Durand S; Ainouze M; Cimarelli A
    J Virol; 2013 Mar; 87(5):2587-96. PubMed ID: 23255800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block.
    Rihn SJ; Foster TL; Busnadiego I; Aziz MA; Hughes J; Neil SJD; Wilson SJ
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Dependent Differences in HIV Inhibition by Different Interferon Alpha Subtypes While Having Overall Similar Biologic Effects.
    Schlaepfer E; Fahrny A; Gruenbach M; Kuster SP; Simon V; Schreiber G; Speck RF
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Type I Interferon Subtypes Differentially Stimulate T Cell Responses in HIV-1-Infected Individuals.
    Karakoese Z; Schwerdtfeger M; Karsten CB; Esser S; Dittmer U; Sutter K
    Front Immunol; 2022; 13():936918. PubMed ID: 35911692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
    Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption.
    Gondim MVP; Sherrill-Mix S; Bibollet-Ruche F; Russell RM; Trimboli S; Smith AG; Li Y; Liu W; Avitto AN; DeVoto JC; Connell J; Fenton-May AE; Pellegrino P; Williams I; Papasavvas E; Lorenzi JCC; Salantes DB; Mampe F; Monroy MA; Cohen YZ; Heath S; Saag MS; Montaner LJ; Collman RG; Siliciano JM; Siliciano RF; Plenderleith LJ; Sharp PM; Caskey M; Nussenzweig MC; Shaw GM; Borrow P; Bar KJ; Hahn BH
    Sci Transl Med; 2021 Jan; 13(576):. PubMed ID: 33441429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.
    Lavender KJ; Gibbert K; Peterson KE; Van Dis E; Francois S; Woods T; Messer RJ; Gawanbacht A; Müller JA; Münch J; Phillips K; Race B; Harper MS; Guo K; Lee EJ; Trilling M; Hengel H; Piehler J; Verheyen J; Wilson CC; Santiago ML; Hasenkrug KJ; Dittmer U
    J Virol; 2016 Jul; 90(13):6001-6013. PubMed ID: 27099312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users.
    Etemad B; Gonzalez OA; White L; Laeyendecker O; Kirk GD; Mehta S; Sagar M
    Retrovirology; 2014 Nov; 11():106. PubMed ID: 25430652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I Interferons in NeuroHIV.
    Thaney VE; Kaul M
    Viral Immunol; 2019; 32(1):7-14. PubMed ID: 30260742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection.
    Schwerdtfeger M; Dickow J; Schmitz Y; Francois S; Karakoese Z; Malyshkina A; Knuschke T; Dittmer U; Sutter K
    Front Immunol; 2021; 12():809774. PubMed ID: 35126368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.